APA (7th ed.) Citation

NA, A., MA, G., MG, A., T, A., AA, A., & AB, M. (2026). Recombinant adenoviruses application for cancer vaccines: From genetic design to clinical translation. Frontiers in oncology, 16, 1824087. https://doi.org/10.3389/fonc.2026.1824087

Chicago Style (17th ed.) Citation

NA, Almarghalani, Ganash MA, Alharbi MG, Abualfaraj T, Alkayyal AA, and Mahmoud AB. "Recombinant Adenoviruses Application for Cancer Vaccines: From Genetic Design to Clinical Translation." Frontiers in Oncology 16 (2026): 1824087. https://doi.org/10.3389/fonc.2026.1824087.

MLA (9th ed.) Citation

NA, Almarghalani, et al. "Recombinant Adenoviruses Application for Cancer Vaccines: From Genetic Design to Clinical Translation." Frontiers in Oncology, vol. 16, 2026, p. 1824087, https://doi.org/10.3389/fonc.2026.1824087.